349
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluations

Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause

, MD & , MD
Pages 2407-2420 | Published online: 07 Oct 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Lynne LL Robinson & Khaled MK Ismail. (2015) Clinical epidemiology of premenstrual disorder: informing optimized patient outcomes. International Journal of Women's Health 7, pages 811-818.
Read now
Sri Harsha Tella & John Christopher Gallagher. (2014) Efficacy of desvenlafaxine succinate for menopausal hot flashes. Expert Opinion on Pharmacotherapy 15:16, pages 2407-2418.
Read now
Maryam Sharifi & E Michael Lewiecki. (2014) Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy. Expert Review of Clinical Pharmacology 7:3, pages 281-291.
Read now

Articles from other publishers (9)

Haoran Wang, Ji Wu, Boyao Wang, Hu Qin, Lei Fan, Yunhua Wang & Bin He. (2023) Progress in Prevention and Treatment of Acute Bone Loss in Orthopedics. International Journal of Endocrinology 2023, pages 1-10.
Crossref
Li-Ting Wang, Li-Ru Chen & Kuo-Hu Chen. (2023) Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview. International Journal of Molecular Sciences 24:6, pages 5814.
Crossref
Chu-Han Cheng, Li-Ru Chen & Kuo-Hu Chen. (2022) Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover. International Journal of Molecular Sciences 23:3, pages 1376.
Crossref
Jilai Tian, Xiang Chen, Shengling Fu, Ruijie Zhang, Li Pan, Yang Cao, Xiaojuan Wu, Hui Xiao, Huey-Jen Lin, Hui-Wen Lo, Ying Zhang & Jiayuh Lin. (2019) Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer. Breast Cancer Research and Treatment 175:3, pages 553-566.
Crossref
N. Chabbert-Buffet, A. Thomin, S. Ouzounian & E. Darai. (2016) Moduladores selectivos de los receptores estrogénicos (MSRE). EMC - Ginecología-Obstetricia 52:3, pages 1-10.
Crossref
Polyzois Makras, Sideris Delaroudis & Athanasios D. Anastasilakis. (2015) Novel therapies for osteoporosis. Metabolism 64:10, pages 1199-1214.
Crossref
Rinu Pazhekattu, Arthur N. Lau & Jonathan D. Adachi. (2015) The Tissue-Selective Estrogen Complex: A Review of Current Evidence. Rheumatology and Therapy 2:1, pages 47-58.
Crossref
Sri Harsha Tella & J. Christopher Gallagher. (2014) Biological agents in management of osteoporosis. European Journal of Clinical Pharmacology 70:11, pages 1291-1301.
Crossref
. (2014) Practice Bulletin No. 141. Obstetrics & Gynecology 123:1, pages 202-216.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.